Replimune Group, Inc. (REPL)
NASDAQ: REPL · IEX Real-Time Price · USD
8.17
-0.08 (-0.97%)
At close: Mar 28, 2024, 4:00 PM
8.49
+0.32 (3.92%)
After-hours: Mar 28, 2024, 7:39 PM EDT

Replimune Group Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Year 2022202120202019201820172016
Net Income
-174.28-118.04-80.87-52.63-30.83-19.7-7.7
Depreciation & Amortization
2.452.151.710.530.150.110.12
Share-Based Compensation
28.1324.2511.797.742.730.810.21
Other Operating Activities
15.669.465.98-16.22.582.770.3
Operating Cash Flow
-128.05-82.18-61.39-60.55-25.38-16.01-7.08
Capital Expenditures
-2.27-2.34-2.39-6.54-2.6-0.14-0.24
Change in Investments
-140.230.53-186.381.31-63.34-43.910
Investing Cash Flow
-142.5-1.81-188.78-5.23-65.94-44.05-0.24
Share Issuance / Repurchase
283.516.86383.590.58103.5500
Debt Issued / Paid
27.79-0.26-11.049.59000
Other Financing Activities
-----2.1654.7515
Financing Cash Flow
311.36.6372.46100.17101.3954.7515
Exchange Rate Effect
-0.110.820.72-0.14-0.842.3-1.42
Net Cash Flow
40.64-76.57123.0234.259.23-3.016.27
Free Cash Flow
-130.32-84.52-63.78-67.09-27.98-16.15-7.32
Free Cash Flow Per Share
-2.24-1.62-1.38-1.96-1.21-3.24-1.47
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).